Keratoconus

BARCELONA, Spain — One-year results with the second-generation ELZA-sub400 protocol for corneal cross-linking showed efficacy in halting keratoconus progression in ultrathin corneas, according to a study presented here.

Cataract surgery is a highly refined procedure nowadays.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Jorge L. Alió del Barrio, MD, PhD, speaks about an AI-based project for the automated early diagnosis of keratoconus.

Atopic dermatitis appears to have a significant yet unidirectional causal effect on the risk for keratoconus, according to a study published in Translational Vision Science & Technology.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Soosan Jacob, MS, FRCS, DNB, discusses custom-shaped CAIRS for the treatment of keratoconus.

Megatrends happen in ophthalmology when new technology addresses existing patient needs and is met with physician acceptance. There’s no better example of this than the current landscape in glaucoma.

Roy Rubinfeld’s description of his experience as a clinician innovator is typical of those who attempt to bring a new drug, device or diagnostic from the bench to the bedside.

In the world of technology, disruptors are sought-after and celebrated. When Roy S. Rubinfeld, MD, MA, led the charge to innovate a new way to do corneal cross-linking, he expected the same response.

Roy Rubinfeld and I share a unique connection.

There has been a sea change in the care of patients with keratoconus in the U.S. since the FDA approval of iLink corneal collagen cross-linking in 2016.